Rgenta Therapeutics Funding & Investors
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.
rgentatx.comTotal Amount Raised: $116,949,200
Rgenta Therapeutics Funding Rounds
Series A
$8,000,000
Series A Investors
Leukemia & Lymphoma SocietyHighLight CapitalSeries A
$52,000,000
Series A Investors
Delos Capital ManagementLegend StarLilly Asia VenturesCICCVivo CapitalBoehringer Ingelheim VentureAstraZenecaMatrix Partners ChinaKorean Investment PartnersKaitai CapitalSeries Unknown
$8,914,283
Seed
$18,000,000
Seed Investors
Lilly Asia VenturesVivo CapitalKaitai CapitalSeed
$20,000,000
Seed Investors
Legend StarBoehringer Ingelheim VentureMatrix Partners ChinaKaitai CapitalSeries Unknown
$10,034,915
Funding info provided by Diffbot.